Serious Neurologic Manifestations Tied to Worse COVID-19 Outcomes
For adults hospitalized with SARS-CoV-2 infection, encephalopathy at admission is the most common serious neurologic manifestation.
For adults hospitalized with SARS-CoV-2 infection, encephalopathy at admission is the most common serious neurologic manifestation.
Stroke-associated pneumonia research over the past 2 decades has yielded significant insight into SAP risk factors, diagnostic measures, and management strategies.
In this meta-analysis, researchers assessed the relationship between 4 infectious bacteria and the risk for ischemic stroke.
Researchers sought to identify the neuropathologic changes of COVID-19 in the olfactory region of patients who died with COVID-19 infection.
The incidence of Guillain-Barré syndrome is increased after Ad.26.COV2.S vaccination, but incidence is not increased after mRNA vaccination.
Increasing access to residential green space may be associated with modest benefits in cognition in adult women.
Researchers assessed whether the increased risk for dementia observed among older adults diagnosed with bacterial pneumonia differs by causative pathogen.
Researchers sought to assess the qualitative effects of COVID-19 on patients with migraine who never tested positive for or been diagnosed with COVID-19.
In a retrospective descriptive study, researchers analyzed the occurrence of stroke per million doses of the COVID-19 vaccines among adult patients hospitalized during an 8-month period.
Researchers assessed whether computerized cognitive training programs were associated with improvements in overall cognitive and daily function in patients with HIV infection.